UNITED THERAPEUTICS Corp — Director's Dealing 2014

Dec 2, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: UNITED THERAPEUTICS Corp (UTHR)
CIK: 0001082554
Period of Report: 2014-12-01

Reporting Person: ROTHBLATT MARTINE A (Director, CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-12-01	Common Stock	M	2592	$52.65	Acquired	2732	Direct
2014-12-01	Common Stock	S	1192	$131.98	Disposed	1540	Direct
2014-12-01	Common Stock	S	600	$132.90	Disposed	940	Direct
2014-12-01	Common Stock	S	500	$134.00	Disposed	440	Direct
2014-12-01	Common Stock	S	300	$134.86	Disposed	140	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-12-01	Stock Options	$52.65	M	2592	Disposed	2019-12-31	Common Stock (2592)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	166	Indirect
Common Stock	533094.05	Indirect

Footnotes

F1: This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.

F2: This transaction was executed in multiple trades at prices ranging from $131.48 to $132.43. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3: This transaction was executed in multiple trades at prices ranging from $132.50 to $133.43. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F4: This transaction was executed in multiple trades at prices ranging from $133.53 to $134.33. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F5: This transaction was executed in multiple trades at prices ranging from $134.71 to $135.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.